Comparing the efficacy of continuous erythropoietin receptor activator and darbepoetin alfa treatments in Japanese patients with chronic kidney disease during the predialysis period: A propensity‐matched analysis

ConclusionOur study showed that C.E.R.A. may be more effective than DA for management of anemia during the predialysis period in CKD patients. This article is protected by copyright. All rights reserved.

Source: Nephrology - October 11, 2015 Category: Urology & Nephrology Authors: Kiyoto Koibuchi, Moriatsu Miyagi, Taichi Arai, Toshiyuki Aoki, Atsushi Aikawa, Ken Sakai Tags: Supplement Article Source Type: research